Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

Davis, SM; Donnan, GA; Parsons, MW; Levi, C; Butcher, KS; Peeters, A; Barber, PA; Bladin, C; De Silva, DA; Byrnes, G; Chalk, JB; Fink, JN; Kimber, TE; Schultz, D; Hand, PJ; Frayne, J; Hankey, G; Muir, K; Gerraty, R; Tress, BM; Desmond, PM

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

journal contribution

posted on 2024-06-04, 06:26 authored by SM Davis, GA Donnan, MW Parsons, C Levi, KS Butcher, A Peeters, PA Barber, C Bladin, DA De Silva, G Byrnes, JB Chalk, JN Fink, TE Kimber, D Schultz, PJ Hand, J Frayne, G Hankey, K Muir, R Gerraty, BM Tress, PM Desmond

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

History

Journal

The Lancet Neurology

Volume

7

Pagination

299-309

Location

England

Publisher DOI

https://doi.org/10.1016/S1474-4422(08)70044-9

ISSN

1474-4422

eISSN

1474-4465

Language

en

Publication classification

C1.1 Refereed article in a scholarly journal

Issue

4

Publisher

Elsevier BV

Usage metrics

Keywords

Aged Aged, 80 and over Double-Blind Method Drug Evaluation Echo-Planar Imaging Female Fibrinolytic Agents Humans Male Middle Aged Placebos Prospective Studies Retrospective Studies Severity of Illness Index Stroke Thrombolytic Therapy Time Factors Tissue Plasminogen Activator Treatment Outcome

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

History

Journal

Volume

Pagination

Location

Publisher DOI

ISSN

eISSN

Language

Publication classification

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports